(2018 – 2023)Biologics Market Report – CAGR Status, Market Growth, Trends, Analysis and Forecasts | 360 Market Updates

Latest Report Titled On:- Global Biologics Market – Segmented by Product and Applications – Growth, Trends and Forecasts (2018 – 2023)


Global “Biologics Market” report provides a detailed analysis of the market from 2018 to 2023. Biologics market report focuses on market capacity, share, current market trends and upcoming future predictions. Global Biologics Market is expected to register a CAGR of approximately 10.5% during the forecast period of (2018 – 2023).

360 MARKET UPDATES Report provides a 360-degree overview of the global Biologics Market with special emphasis on all aspects including CAGR Status, drivers, restraints, and opportunities, market and regional segmentation.


Get Sample PDF of Report – https://www.360marketupdates.com/enquiry/request-sample/12883909

The global biologics market is expected to register a CAGR of about 10.5% during 2018-2023 (the forecast period). Due to the growing demand for biologics treatment for chronic diseases, North America is dominating the market.

Increasing Capital Investment by the Key Market Players

In 2016, biologics accounted for six of the top-eight drugs, in terms of revenue. AbbVie’s Humira (adalimumab) for rheumatoid arthritis, psoriasis, Crohn’s, and other autoimmune diseases led the way, with a total of USD 18.4 billion sales. The growing success rate of biologics drugs and their demand have led to huge capital investment for the expansion of commercial biologics manufacturing capacities, among CMO and big pharmaceutical companies. For instance, Novartis AG invested around USD 700 million in its biologics facility in Singapore, and Bristol-Myers Squibb invested nearly USD 900 million in an Irish large-scale biologics facility that is anticipated to be completed by 2019. In addition, the rise in the prevalence of chronic diseases, loss of patent exclusivity of the leading biologics drugs, and growing demand and higher acceptability for innovative therapies are the factors driving the global biologics market growth.

Stringent Regulatory Process and High Capital Investment

Biologics drugs are highly complex and require controlled conditions and maintenance, throughout the development and production process. Such regulated environment and quality-control procedures involve huge capital in the initial phase of process. Further, biologics are extremely susceptible to light, heat conditions, and need extremely favorable environment that is not available uniformly across the globe. In most emerging markets, biologics currently have little-to-no presence. Stringent regulatory policies and high-capital investment, coupled with limited patient access to affordable biologics, especially in the developing countries, owing to the rising control and cost for accessing biologics, are likely to impede the growth of the global biologics market.

North America to Dominate the Market

The biologics market has been segmented on the basis of product type, application, and geography. By geography, the market has been categorized into North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
Owing to the presence of well-established pharmaceuticals companies and increase in the number of biotech companies, being funded by venture capital, North America is dominating the biologics market. Asia-Pacific is also expected to grow at a great pace during forecast period, owing to factors, such as rise in the outsourcing of biologics contract manufacturing in emerging countries of the region, less stringent regulatory environment for clinical trials of drugs, and the growing awareness regarding the success of biologics for the treatment of chronic diseases.

Order a Copy Of Biologics Market Report  https://www.360marketupdates.com/purchase/12883909

Reasons to Purchase Biologics Market Report:

  • Identification of key factors instrumental in changing the market scenario, exploiting new opportunities, and gaining a competitive edge. 
  • Analysing various perspectives of the market with the help of Porter’s five forces analysis.
  • The authentication mode is likely to witness the highest adoption of these systems in the market.
  • The regions that are expected to witness the fastest growth during the forecast period.
  • The SWOT analysis for key players and a detailed study of their current strategic interests and key financial performance indicators.
  • 3 months’ analyst support along with the Market Estimate sheet (in excel). 

“We also can offer customized report to fulfill special requirements of our clients. Regional and Countries report can be provided as well.”

About 360 Market Updates:

360 Market Updates is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Market Updates, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

Contact Us:

Name: Mr. Ajay More

Email: [email protected]

Organization: 360 Market Updates

Phone: +14242530807/+44 203 239 8187

Tagged: Google News, Biologics Market, Biologics Europe Market, Biologics APAC Market, Biologics Market By Application, Biologics Market By Rising Trends, Biologics Market Development, Biologics Market Forecast, Biologics Market Future, Biologics Market Growth, Biologics Market In Key Countries, Biologics Market Latest Report, Biologics Market Swot Analysis, Biologics Market Top Manufacturers, Biologics Sales Market, Biologics United States Market

Leave a Reply

Your email address will not be published. Required fields are marked *